4-aminopyridine methiodide has been researched along with alpha-aminopyridine in 5 studies
| Studies (4-aminopyridine methiodide) | Trials (4-aminopyridine methiodide) | Recent Studies (post-2010) (4-aminopyridine methiodide) | Studies (alpha-aminopyridine) | Trials (alpha-aminopyridine) | Recent Studies (post-2010) (alpha-aminopyridine) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 5,813 | 460 | 3,246 |
| Protein | Taxonomy | 4-aminopyridine methiodide (IC50) | alpha-aminopyridine (IC50) |
|---|---|---|---|
| Botulinum neurotoxin type A | Clostridium botulinum | 1.8 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.8 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 6 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 9 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 1.9 | |
| Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | 7.1 | |
| Phosphatidylinositol 4-kinase type 2-beta | Homo sapiens (human) | 7.1 | |
| Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | 7.1 | |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | 7.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, T; Hiraoka, M; Yamane, T | 1 |
| Garratt, JC; Owen, DG; Robertson, B; Stephens, GJ | 1 |
| Hirsh, JK; Quandt, FN | 1 |
| Ding, WG; Kawai, H; Maeda, K; Maegawa, H; Matsuura, H; Nakamura, H; Sanada, M | 1 |
| Chen, B; Gu, X; He, Z; Li, W; Li, Y; Liu, Y; Wang, X; Williams, PR; Yu, B; Zhang, Q; Zhang, Y; Zhang, Z; Zhu, J | 1 |
5 other study(ies) available for 4-aminopyridine methiodide and alpha-aminopyridine
| Article | Year |
|---|---|
4-Aminopyridine block of the noninactivating cloned K+ channel Kv1.5 expressed in Xenopus oocytes.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Cloning, Molecular; Dose-Response Relationship, Drug; Electric Stimulation; Hydrogen-Ion Concentration; Kinetics; Models, Cardiovascular; Myocardium; Oocytes; Osmolar Concentration; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Rats; Xenopus laevis | 1995 |
On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1.
Topics: 4-Aminopyridine; Amino Acid Sequence; Aminopyridines; Animals; Brain Chemistry; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Hydrogen-Ion Concentration; Ion Channel Gating; Membrane Potentials; Mice; Molecular Sequence Data; Patch-Clamp Techniques; Peptide Fragments; Potassium Channel Blockers; Potassium Channels; Transfection | 1994 |
Aminopyridine block of potassium channels in mouse neuroblastoma cells.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Binding Sites; Mice; Neuroblastoma; Potassium Channels; Tumor Cells, Cultured | 1993 |
Presence and functional role of the rapidly activating delayed rectifier K(+) current in left and right atria of adult mice.
Topics: Action Potentials; Aminopyridines; Animals; Atrial Function; Cells, Cultured; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart Atria; Kinetics; Kv1.5 Potassium Channel; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Organ Specificity; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Pyridines | 2010 |
A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions.
Topics: Age Factors; Aminopyridines; Animals; Axotomy; Disease Models, Animal; Functional Laterality; Hindlimb; Insulin-Like Growth Factor I; Mice; Movement Disorders; Neurons; Osteopontin; Psychomotor Performance; Pyramidal Tracts; Recovery of Function; Reflex; Serotonin; Spinal Cord Injuries; Stroke; Time Factors | 2017 |